Literature DB >> 21874034

A20 edits ubiquitin and autoimmune paradigms.

Flavius Martin, Vishva M Dixit.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21874034     DOI： 10.1038/ng.916

Source DB:  PubMed          Journal:  Nat Genet        ISSN： 1061-4036            Impact factor:   38.330


× No keyword cloud information.
  12 in total

Review 1.  A20: central gatekeeper in inflammation and immunity.

Authors:  Beatrice Coornaert; Isabelle Carpentier; Rudi Beyaert
Journal:  J Biol Chem       Date:  2008-11-13       Impact factor: 5.157

2.  Keratinocyte-specific ablation of the NF-κB regulatory protein A20 (TNFAIP3) reveals a role in the control of epidermal homeostasis.

Authors:  S Lippens; S Lefebvre; B Gilbert; M Sze; M Devos; K Verhelst; L Vereecke; C Mc Guire; C Guérin; P Vandenabeele; M Pasparakis; M L Mikkola; R Beyaert; W Declercq; G van Loo
Journal:  Cell Death Differ       Date:  2011-05-13       Impact factor: 15.828

Review 3.  A20: from ubiquitin editing to tumour suppression.

Authors:  Sarah G Hymowitz; Ingrid E Wertz
Journal:  Nat Rev Cancer       Date:  2010-04-12       Impact factor: 60.716

4.  A20 deficiency in B cells enhances B-cell proliferation and results in the development of autoantibodies.

Authors:  Nadine Hövelmeyer; Sonja Reissig; Nguyen Thi Xuan; Petra Adams-Quack; Dominika Lukas; Alexei Nikolaev; Dirk Schlüter; Ari Waisman
Journal:  Eur J Immunol       Date:  2011-02-10       Impact factor: 5.532

Review 5.  Targeting lymphocyte co-stimulation: from bench to bedside.

Authors:  Nathan J Felix; Anish Suri; Luisa Salter-Cid; Steven G Nadler; Sheila Gujrathi; Michael Corbo; Richard Aranda
Journal:  Autoimmunity       Date:  2010-11       Impact factor: 2.815

6.  The ubiquitin modifying enzyme A20 restricts B cell survival and prevents autoimmunity.

Authors:  Rita M Tavares; Emre E Turer; Chih L Liu; Rommel Advincula; Patrizia Scapini; Lesley Rhee; Julio Barrera; Clifford A Lowell; Paul J Utz; Barbara A Malynn; Averil Ma
Journal:  Immunity       Date:  2010-08-12       Impact factor: 31.745

7.  B cells lacking the tumor suppressor TNFAIP3/A20 display impaired differentiation and hyperactivation and cause inflammation and autoimmunity in aged mice.

Authors:  Yuanyuan Chu; J Christoph Vahl; Dilip Kumar; Klaus Heger; Arianna Bertossi; Edyta Wójtowicz; Valeria Soberon; Dominik Schenten; Brigitte Mack; Miriam Reutelshöfer; Rudi Beyaert; Kerstin Amann; Geert van Loo; Marc Schmidt-Supprian
Journal:  Blood       Date:  2010-11-18       Impact factor: 22.113

8.  A20 (TNFAIP3) deficiency in myeloid cells triggers erosive polyarthritis resembling rheumatoid arthritis.

Authors:  Mourad Matmati; Peggy Jacques; Jonathan Maelfait; Eveline Verheugen; Mirjam Kool; Mozes Sze; Lies Geboes; Els Louagie; Conor Mc Guire; Lars Vereecke; Yuanyuan Chu; Louis Boon; Steven Staelens; Patrick Matthys; Bart N Lambrecht; Marc Schmidt-Supprian; Manolis Pasparakis; Dirk Elewaut; Rudi Beyaert; Geert van Loo
Journal:  Nat Genet       Date:  2011-08-14       Impact factor: 38.330

9.  The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses.

Authors:  David L Boone; Emre E Turer; Eric G Lee; Regina-Celeste Ahmad; Matthew T Wheeler; Colleen Tsui; Paula Hurley; Marcia Chien; Sophia Chai; Osamu Hitotsumatsu; Elizabeth McNally; Cecile Pickart; Averil Ma
Journal:  Nat Immunol       Date:  2004-08-29       Impact factor: 25.606

10.  Enterocyte-specific A20 deficiency sensitizes to tumor necrosis factor-induced toxicity and experimental colitis.

Authors:  Lars Vereecke; Mozes Sze; Conor Mc Guire; Brecht Rogiers; Yuanyuan Chu; Marc Schmidt-Supprian; Manolis Pasparakis; Rudi Beyaert; Geert van Loo
Journal:  J Exp Med       Date:  2010-06-07       Impact factor: 14.307
View more
  16 in total

1.  TNFAIP3 promotes survival of CD4 T cells by restricting MTOR and promoting autophagy.

Authors:  Yu Matsuzawa; Shigeru Oshima; Masahiro Takahara; Chiaki Maeyashiki; Yasuhiro Nemoto; Masanori Kobayashi; Yoichi Nibe; Kengo Nozaki; Takashi Nagaishi; Ryuichi Okamoto; Kiichiro Tsuchiya; Tetsuya Nakamura; Averil Ma; Mamoru Watanabe
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

2.  Fine mapping of eight psoriasis susceptibility loci.

Authors:  Sayantan Das; Philip E Stuart; Jun Ding; Trilokraj Tejasvi; Yanming Li; Lam C Tsoi; Vinod Chandran; Judith Fischer; Cynthia Helms; Kristina Callis Duffin; John J Voorhees; Anne M Bowcock; Gerald G Krueger; G Mark Lathrop; Rajan P Nair; Proton Rahman; Goncalo R Abecasis; Dafna Gladman; James T Elder
Journal:  Eur J Hum Genet       Date:  2014-09-03       Impact factor: 4.246

3.  Elevated A20 contributes to age-dependent macrophage dysfunction in the lungs.

Authors:  Cecilia A Hinojosa; Ramya Akula Suresh Babu; Md M Rahman; Gabriel Fernandes; Angela R Boyd; Carlos J Orihuela
Journal:  Exp Gerontol       Date:  2014-01-17       Impact factor: 4.032

Review 4.  Lessons from characterization and treatment of the autoinflammatory syndromes.

Authors:  Ivona Aksentijevich; Michael F McDermott
Journal:  Curr Opin Rheumatol       Date:  2017-03       Impact factor: 5.006

5.  Induction of the inflammatory regulator A20 by gibberellic acid in airway epithelial cells.

Authors:  J A Reihill; B Malcomson; A Bertelsen; S Cheung; A Czerwiec; R Barsden; J S Elborn; H Dürkop; B Hirsch; M Ennis; C Kelly; B C Schock
Journal:  Br J Pharmacol       Date:  2015-07-21       Impact factor: 8.739

Review 6.  Dendritic cells: an important link between antiphospholipid antibodies, endothelial dysfunction, and atherosclerosis in autoimmune and non-autoimmune diseases.

Authors:  Anna Broder; Jimmy J Chan; Chaim Putterman
Journal:  Clin Immunol       Date:  2012-12-20       Impact factor: 3.969

7.  Lysine 63-linked ubiquitination modulates mixed lineage kinase-3 interaction with JIP1 scaffold protein in cytokine-induced pancreatic β cell death.

Authors:  Rohan K Humphrey; Shu Mei A Yu; Aditi Bellary; Sumati Gonuguntla; Myra Yebra; Ulupi S Jhala
Journal:  J Biol Chem       Date:  2012-11-21       Impact factor: 5.157

8.  Enhanced meta-analysis and replication studies identify five new psoriasis susceptibility loci.

Authors:  Lam C Tsoi; Sarah L Spain; Eva Ellinghaus; Philip E Stuart; Francesca Capon; Jo Knight; Trilokraj Tejasvi; Hyun M Kang; Michael H Allen; Sylviane Lambert; Stefan W Stoll; Stephan Weidinger; Johann E Gudjonsson; Sulev Koks; Külli Kingo; Tonu Esko; Sayantan Das; Andres Metspalu; Michael Weichenthal; Charlotta Enerback; Gerald G Krueger; John J Voorhees; Vinod Chandran; Cheryl F Rosen; Proton Rahman; Dafna D Gladman; Andre Reis; Rajan P Nair; Andre Franke; Jonathan N W N Barker; Goncalo R Abecasis; Richard C Trembath; James T Elder
Journal:  Nat Commun       Date:  2015-05-05       Impact factor: 14.919

Review 9.  The IL-23/IL-17 axis in psoriatic arthritis.

Authors:  Erika Suzuki; Elizabeth D Mellins; M Eric Gershwin; Frank O Nestle; Iannis E Adamopoulos
Journal:  Autoimmun Rev       Date:  2014-01-11       Impact factor: 9.754

10.  In Vivo Silencing of A20 via TLR9-Mediated Targeted SiRNA Delivery Potentiates Antitumor Immune Response.

Authors:  Floriane C M Braun; Jens van den Brandt; Sören Thomas; Sandra Lange; Juliane Schrank; Claudia Gand; Grzegorz K Przybylski; Katrin Schmoeckel; Barbara M Bröker; Christian A Schmidt; Piotr Grabarczyk
Journal:  PLoS One       Date:  2015-09-01       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.